Annual Total Expenses
$39.50 M
+$11.27 M+39.94%
December 1, 2023
Summary
- As of February 7, 2025, RVPH annual total expenses is $39.50 million, with the most recent change of +$11.27 million (+39.94%) on December 1, 2023.
- During the last 3 years, RVPH annual total expenses has risen by +$37.07 million (+1522.52%).
- RVPH annual total expenses is now at all-time high.
Performance
RVPH Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$8.46 M
+$332.90 K+4.09%
September 1, 2024
Summary
- As of February 7, 2025, RVPH quarterly total expenses is $8.46 million, with the most recent change of +$332.90 thousand (+4.09%) on September 1, 2024.
- Over the past year, RVPH quarterly total expenses has dropped by -$3.10 million (-26.82%).
- RVPH quarterly total expenses is now -27.65% below its all-time high of $11.70 million, reached on December 31, 2022.
Performance
RVPH Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RVPH Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.9% | -26.8% |
| 3 y3 years | +1522.5% | -25.4% |
| 5 y5 years | +10000.0% | -25.4% |
RVPH Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +290.9% | -27.6% | +137.5% |
| 5 y | 5-year | at high | >+9999.0% | -27.6% | +2304.1% |
| alltime | all time | at high | >+9999.0% | -27.6% | +2304.1% |
Reviva Pharmaceuticals Holdings Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.46 M(+4.1%) |
| Jun 2024 | - | $8.13 M(+2.6%) |
| Mar 2024 | - | $7.92 M(-17.6%) |
| Dec 2023 | $39.50 M(+39.9%) | $9.62 M(-16.8%) |
| Sep 2023 | - | $11.56 M(+2.0%) |
| Jun 2023 | - | $11.34 M(+62.3%) |
| Mar 2023 | - | $6.98 M(-40.3%) |
| Dec 2022 | $28.23 M | $11.70 M(+228.3%) |
| Sep 2022 | - | $3.56 M(-35.4%) |
| Jun 2022 | - | $5.52 M(-25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $7.45 M(+87.9%) |
| Dec 2021 | $10.10 M(+315.0%) | $3.96 M(+60.1%) |
| Sep 2021 | - | $2.48 M(+38.4%) |
| Jun 2021 | - | $1.79 M(-4.4%) |
| Mar 2021 | - | $1.87 M(+255.4%) |
| Dec 2020 | $2.43 M(+546.0%) | $526.70 K(+49.6%) |
| Nov 2020 | - | $352.00 K(-31.3%) |
| Sep 2020 | - | $512.30 K(-34.1%) |
| Jun 2020 | - | $777.40 K(+25.7%) |
| Mar 2020 | - | $618.30 K |
| Dec 2019 | $376.90 K | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual total expenses?
- What is the all time high annual total expenses for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual total expenses year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly total expenses?
- What is the all time high quarterly total expenses for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly total expenses year-on-year change?
What is Reviva Pharmaceuticals Holdings annual total expenses?
The current annual total expenses of RVPH is $39.50 M
What is the all time high annual total expenses for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual total expenses is $39.50 M
What is Reviva Pharmaceuticals Holdings annual total expenses year-on-year change?
Over the past year, RVPH annual total expenses has changed by +$11.27 M (+39.94%)
What is Reviva Pharmaceuticals Holdings quarterly total expenses?
The current quarterly total expenses of RVPH is $8.46 M
What is the all time high quarterly total expenses for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly total expenses is $11.70 M
What is Reviva Pharmaceuticals Holdings quarterly total expenses year-on-year change?
Over the past year, RVPH quarterly total expenses has changed by -$3.10 M (-26.82%)